Daosheng Huang
- Oncology top 10%
- CAR-T cell therapy research 6
-
- Immune Cell Function and Interaction 3
-
- Pluripotent Stem Cells Research 3
- Single-cell and spatial transcriptomics 2
- vaccines and immunoinformatics approaches 1
- CRISPR and Genetic Engineering 1
- DNA Repair Mechanisms 1
-
- SARS-CoV-2 and COVID-19 Research 1
- Cited by
- OncologyImmunologyGenetics
- Journals
- Journal of Biological Chemistry (1 paper)Scientific Reports (1 paper)Genome biology (1 paper)
- Partner nations
- ChinaUnited StatesSweden
In The Last Decade
Daosheng Huang
11 papers receiving 461 citations
Peers
Comparison fields: 5 of 64
- Oncology 289
- Immunology 146
- Genetics 95
- Molecular Biology 187
- Biomedical Engineering 115
Countries citing papers authored by Daosheng Huang
This map shows the geographic impact of Daosheng Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daosheng Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daosheng Huang more than expected).
Fields of papers citing papers by Daosheng Huang
This network shows the impact of papers produced by Daosheng Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daosheng Huang. The network helps show where Daosheng Huang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Daosheng Huang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 3 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 11 | |
| 5 | 2023 | 21 | |
| 6 | 2023 | 1 | |
| 7 | 2022 | 12 | |
| 8 | 2021 | 113 | |
| 9 | 2020 | 158 | |
| 10 | 2018 | 76 | |
| 11 | 2017 | 57 | |
| 12 | 2015 | 11 |
About Daosheng Huang
Daosheng Huang is a scholar working on Immunology, Oncology and Molecular Medicine, having authored 12 papers that have together received 464 indexed citations. Recurring topics across this work include CAR-T cell therapy research (6 papers), Pluripotent Stem Cells Research (3 papers), Immune Cell Function and Interaction (3 papers), Single-cell and spatial transcriptomics (2 papers), vaccines and immunoinformatics approaches (1 paper), SARS-CoV-2 and COVID-19 Research (1 paper), CRISPR and Genetic Engineering (1 paper) and DNA Repair Mechanisms (1 paper). The work is most often cited by research in Oncology (289 citations), Immunology (146 citations) and Genetics (95 citations). Daosheng Huang has collaborated with scholars based in China, United States and Sweden. Frequent co-authors include Xin Lin, Xueqiang Zhao, Guangna Liu, Wei Rui, Hongli Zheng, Yuewei Zhang, Fei Yu, Jiahong Dong, Guo‐Cheng Yuan and Guoji Guo. Their work appears in journals such as Journal of Biological Chemistry, Scientific Reports and Genome biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.